Evidence map›Paper›PMID 36653413›Full record

ArticleScientific reports2023

A novel NONO variant that causes developmental delay and cardiac phenotypes.

Toshiyuki Itai, Atsushi Sugie, Yohei Nitta, Ryuto Maki, Takashi Suzuki, Yoichi Shinkai, Yoshihiro Watanabe, Yusuke Nakano, Kazushi Ichikawa, Nobuhiko Okamoto and 11 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Turner Syndrome Complicated by aJCEM case reports · 2025
    Article
  8. Insects · 2024
    Review
  9. Article
  10. Article
  11. RNA binding proteins in cardiovascular development and disease.Current topics in developmental biology · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 1 country.

Toshiyuki Itai *Department of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, Kanagawa, Japan.ORCID 0000-0002-9774-0464
Atsushi Sugie *Brain Research Institute, Niigata University, Niigata, Japan.ORCID 0000-0002-2090-8839
Yohei NittaBrain Research Institute, Niigata University, Niigata, Japan.
Ryuto MakiSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Kanagawa, Japan.
Takashi SuzukiSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Kanagawa, Japan.
Yoichi ShinkaiBiomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan.ORCID 0000-0001-8366-6278
Yoshihiro WatanabeChildren's Medical Center, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan.ORCID 0000-0002-5552-5715
Yusuke NakanoDepartment of Pediatric Cardiology, Yokohama City University Hospital, Yokohama, Kanagawa, Japan.ORCID 0000-0002-0899-7971
Kazushi IchikawaDepartment of Pediatrics, Fujisawa City Hospital, Fujisawa, Kanagawa, Japan.ORCID 0000-0002-4492-7233
Nobuhiko OkamotoDepartment of Medical Genetics, Osaka Women's and Children's Hospital, Izumi, Osaka, Japan.
Yasuhiro UtsunoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, Kanagawa, Japan.ORCID 0000-0002-7889-0328
Eriko KoshimizuDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, Kanagawa, Japan.
Atsushi FujitaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, Kanagawa, Japan.
Kohei HamanakaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, Kanagawa, Japan.
Yuri UchiyamaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, Kanagawa, Japan.ORCID 0000-0002-4540-5277
Naomi TsuchidaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, Kanagawa, Japan.ORCID 0000-0001-7203-884X
Noriko MiyakeDepartment of Human Genetics, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Kazuharu MisawaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, Kanagawa, Japan.ORCID 0000-0002-6277-4330
Takeshi MizuguchiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, Kanagawa, Japan.ORCID 0000-0003-4998-1244
Satoko MiyatakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, Kanagawa, Japan.ORCID 0000-0001-7587-5168
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, Kanagawa, Japan. naomat@yokohama-cu.ac.jp.ORCID 0000-0001-9846-6500
Yokohama City University · JPYokohama City University Hospital · JPNiigata University · JPTokyo Institute of Technology · JPFujisawa City Hospital · JPNational Center for Global Health and Medicine · JPNational Institute of Advanced Industrial Science and Technology · JPOsaka Women's and Children's Hospital · JPRIKEN Center for Advanced Intelligence Project · JPYokohama City University Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Drosophila behavior/human splicing protein family is involved in numerous steps of gene regulation. In humans, this family consists of three proteins: SFPQ, PSPC1, and NONO. Hemizygous loss-of-function (LoF) variants in NONO cause a developmental delay with several complications (e.g., distinctive facial features, cardiac symptoms, and skeletal symptoms) in an X-linked recessive manner. Most of the reported variants have been LoF variants, and two missense variants have been reported as likely deleterious but with no functional validation. We report three individuals from two families harboring an identical missense variant that is located in the nuclear localization signal, NONO: NM_001145408.2:c.1375C > G p.(Pro459Ala). All of them were male and the variant was inherited from their asymptomatic mothers. Individual 1 was diagnosed with developmental delay and cardiac phenotypes (ventricular tachycardia and dilated cardiomyopathy), which overlapped with the features of reported individuals having NONO LoF variants. Individuals 2 and 3 were monozygotic twins. Unlike in Individual 1, developmental delay with autistic features was the only symptom found in them. A fly experiment and cell localization experiment showed that the NONO variant impaired its proper intranuclear localization, leading to mild LoF. Our findings suggest that deleterious NONO missense variants should be taken into consideration when whole-exome sequencing is performed on male individuals with developmental delay with or without cardiac symptoms.

Indexed as

Cardiomyopathy, DilatedDNA-Binding ProteinsHeartMutation, MissenseRNA-Binding ProteinsFemaleHumansMalePhenotypeDNA-Binding ProteinsNONO protein, humanPSPC1 protein, humanRNA-Binding Proteins

Identifiers

PMID36653413
PMCPMC9849200
OpenAlexW4317211571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.